W2 O Group

All the email addresses for w2ogroup.com

{f}{last}@w2ogroup.com
94 email addresses
http://blog.wcgworld.com/2014/05/what-walter-white-and-angelina-teach-us-about-cancer-conversation-online June 6, 2016
http://stage.mediacenter.23andme.com/blog/2013/12/05/23andme-inc-provides-update-on-fda-regulatory-review September 9, 2016
http://ptcommunity.com/wire/sarepta-therapeutics-announces-presentations-2017-mda-scientific-conference March 3, 2017
http://biospace.com/news/sarepta-announces-inducement-grants-under-nasdaq/440652 May 5, 2017
http://drugs.com/newdrugs/nextwave-pharmaceuticals-receives-fda-approval-quillivant-xr-once-daily-adhd-3519.html January 1, 2015
http://thenewsreports.com/amicus-therapeutics-prices-underwritten-offering-of-common-stock/28622/staff July 7, 2017
http://firstwordpharma.com/node/1444976 March 3, 2017
http://businesswire.com/news/home/20140423005591/en/91-percent-americans-genetic-information-influence-health January 1, 2015
http://biospace.com/news/sarepta-announces-inducement-grants-under-nasdaq/437639 July 7, 2017
http://jettfoundation.org/news/industry-news-sarepta-therapeutics-enters-an-exclusive-license-agreement-with-nationwide-childrens-hospital-for-gene-therapy-program February 2, 2017
http://firstwordpharma.com/node/1444923 July 7, 2017
http://businesswire.com/news/home/20140423005591/en/91-Percent-Americans-Genetic-Information-Influence-Health May 5, 2015
http://slideshare.net/wcgworld/the-social-oncology-report-2013 January 1, 2015
http://biotech-365.com/sarepta-therapeutics-announces-favorable-uspto-decisions-in-exon-51-and-exon-53-composition-of-matter-patent-interference-cases-against-biomarin-pharmaceutical September 9, 2016
http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-inducement-grants-under-nasdaq-18 August 8, 2017
http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-its-partner-genethon-published August 8, 2017
http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-pricing-325-million-public August 8, 2017
http://promotedstories.com/story/541144 September 9, 2016
http://businesswire.com/news/home/20140620005102/en/23andme-appoints-angela-wonson-vice-president-communications May 5, 2017
http://businesswire.com/news/home/20131205006550/en January 1, 2015
http://multivu.com/mnr/58086-nextwave-pharmaceuticals-quillivant-xr-adhd-treatment-extended-release April 4, 2015
http://yumanity.com/contact September 9, 2017
http://mediacenter.23andme.com/blog/2013/12/05/23andme-inc-provides-update-on-fda-regulatory-review/ October 10, 2015
http://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-present-three-upcoming-investor-conferences August 8, 2017
http://businesswire.com/news/home/20160922006376/en/sarepta-therapeutics-announces-pricing-300-million-public May 5, 2017
http://benzinga.com/pressreleases/16/09/b8473444/sarepta-therapeutics-announces-fda-accelerated-approval-of-exondys-51-e May 5, 2017
http://mediacenter.23andme.com/blog/23andme-inc-provides-update-on-fda-regulatory-review October 10, 2016
http://prnewswire.com/news-releases/first-of-its-kind-study-by-kaiser-permanente-examines-gaps-in-how-physicians-media-and-policymakers-talk-about-health-193271131.html January 1, 2015
http://thenewsreports.com/sarepta-therapeutics-and-clinigen-launch-a-managed-access-program-to-treat-patients-with-duchenne-muscular-dystrophy-amenable-to-exon-51-skipping/28823/staff July 7, 2017
http://thenewsreports.com/sarepta-therapeutics-announces-second-quarter-2017-financial-results-and-recent-corporate-developments/28873/staff July 7, 2017
http://benzinga.com/pressreleases/16/09/b8435922/incyte-supports-those-affected-by-rare-blood-cancers-on-mpn-awareness-d July 7, 2017
http://cslbehring.com/s1/cs/enco/1255923338532/news/1252904371089/prdetail.htm March 3, 2017
http://newswire.ca/news-releases/new-england-journal-of-medicine-publishes-pivotal-phase-iii-data-for-csl-behrings-subcutaneous-c1-esterase-inhibitor-in-hae-patients-618117513.html August 8, 2017
http://bioflorida.com/news/news.asp May 5, 2016
http://amigobulls.com/news/esperion-announces-initiation-of-three-pivotal-phase-3-studies-for-bempedoic-acid July 7, 2017
http://life-sciences-france.com/news/ipsen-acquires-oncology-assets-euronext-ipn-group-merrimack-2001-109993.html March 3, 2017
http://benzinga.com/pressreleases/16/06/g8162374/esperion-therapeutics-provides-clinical-development-and-regulatory-upda May 5, 2017
http://bioflorida.site-ym.com/news/289838/-therapeuticsmd-presents-poster-at-acog-2016-with-additional-secondary-endpoint-data-from-phase-3....htm August 8, 2016
http://cslbehring.com/s1/cs/enco/1151517262804/news/1252904371089/prdetail.htm March 3, 2017
http://newswire.ca/fr/news-releases/ipsen-modifie-laccord-de-licence-conclu-avec-exelixis-afin-de-commercialiser-et-de-developper-le-cabozantinib-au-canada-607945676.html June 6, 2017
http://businesswire.com/news/home/20140617006659/en/esperion-therapeutics-present-jmp-securities-healthcare-conference January 1, 2015
http://traderpower.com/espr-fda-confirmation-pathway-to-approval-for-an-ldl-c July 7, 2017
http://benzinga.com/pressreleases/16/10/g8557863/bempedoic-acid-global-phase-3-clinical-program-to-include-patients-on-a July 7, 2017
http://stockguru.com/2016/10/13/bempedoic-acid-global-phase-3-clinical-program-to-include-patients-on-any-statin-at-any-dose March 3, 2017
http://businesswire.com/news/home/20140505005302/en/esperion-therapeutics-provide-quarter-2014-financial-results January 1, 2015
http://esperion.com/meet-esperion/media-kit March 3, 2016
http://biospace.com/News/esperion-therapeutics-inc-to-present-at-jmp/337296 April 4, 2015
http://businesswire.com/news/home/20140324005691/en/esperion-therapeutics-present-biocentury-future-leaders-biotech January 1, 2015
http://businesswire.com/news/home/20140213005462/en/esperion-therapeutics-names-mark-e.-mcgovern-m.d January 1, 2015
http://marketwatchus.wsj.akadns.net/story/therapeuticsmd-presents-poster-at-acog-2016-with-additional-secondary-endpoint-data-from-phase-3-rejoice-trial-2016-05-14 May 5, 2016
http://esperion.com/meet-esperion/media-kit/ September 9, 2015
http://biospace.com/news/esperion-therapeutics-inc-to-present-at-jmp/337296 July 7, 2015
http://businesswire.com/news/home/20140716006383/en/esperion-therapeutics-host-inaugural-analyst-investor-day February 2, 2015
http://vbprofiles.com/press_releases/57376fd330d3fc8ea9000032 May 5, 2016
http://marketwired.com/press-release/esperion-therapeutics-announces-two-oral-presentations-etc-1002-american-heart-association-2070439.htm August 8, 2017
http://investor.esperion.com/printed-materials.cfm May 5, 2017
http://aacr.org/newsroom/pages/media-advisory-listing.aspx October 10, 2016
http://domainvc.com/news/esperion-completes-enrollment-of-pivotal-phase-3-long-term-safety-and-toler February 2, 2017
http://cslbehring.com/news-room/nejm-publishes-data-on-preventing-hae-attacks.htm March 3, 2017
http://domainvc.com/news/esperion-announces-oral-presentation-on-genetic-validation-of-atp-citrate-l March 3, 2017
http://adverum.gcs-web.com/news-releases/news-release-details/avalanche-biotechnologies-presents-three-posters-american July 7, 2017
http://adverum.gcs-web.com/news-releases/news-release-details/avalanche-biotechnologies-inc-reports-third-quarter-2015 July 7, 2017
http://adverum.gcs-web.com/news-releases/news-release-details/avalanche-biotechnologies-inc-announces-positive-top-line-phase July 7, 2017
http://adverum.gcs-web.com/news-releases/news-release-details/avalanche-biotechnologies-inc-reports-second-quarter-2015 July 7, 2017
http://adverum.gcs-web.com/news-releases/news-release-details/avalanche-biotechnologies-inc-reports-first-quarter-2015 July 7, 2017
http://everyonewhosanyone.com/other1.html January 1, 2016
http://myrtlepotterconsulting.com/portfolio_1/proteus-digital-health-expands-commercial-team-board-directors-drive-commercial-growth July 7, 2016
http://investors.avalanchebiotech.com/phoenix.zhtml October 10, 2016
http://investors.adverum.com/news-releases/news-release-details/avalanche-biotechnologies-inc-reports-first-quarter-2015 September 9, 2017
http://investors.adverum.com/news-releases/news-release-details/avalanche-biotechnologies-presents-three-posters-american September 9, 2017
http://investors.adverum.com/news-releases/news-release-details/avalanche-biotechnologies-inc-announces-positive-top-line-phase September 9, 2017
http://investors.adverum.com/news-releases/news-release-details/avalanche-biotechnologies-inc-reports-second-quarter-2015 September 9, 2017
http://investors.adverum.com/news-releases/news-release-details/avalanche-biotechnologies-inc-reports-third-quarter-2015 September 9, 2017

Please log in to uncover the email addresses, access the 94 results for w2ogroup.com, filters and more.

Create a free account

Already have an account? Sign in

More information about w2ogroup.com

Industry: Internet and Telecom

Language of the website: English

Main technologies used:

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.